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ABSTRACT
A modified in vitro repZication system has been characterized and
used to catalogue the host proteins required for the replication of plasmid
RSF1030. These extracts differ from systems described previousZy in that
endogenous DNA is removed. RepZication in vitro-therefore requires an exo-
genouos RSF1030 terplate, even when extracts are prepared from ceZZs carry-
ing endogenous RSF1030. Synthesis in the in vitro system faithfuZZy mimics
in vivo replication with respect to the products synthesized, effects of
specific inhibitors, and requirements for RNA polymerase and DNA polymerase
I. In addition, we find that proteins encoded by dnaB, dnaC dnaG, dnaI,
dnaP and poZC (DNA poZymerase III), are required for in vitro plasmid
synthesis. The product of dnaA is not required. Extracts prepared from
E. coZi mutants deficient in in vitro repZication can be compZemented by
addition of purified proteins or of extracts carrying the wild type protein.
INTRODUCTION
Two in vitro systems have been described for the replication of plas-
mid DNA's, one by Sakakibara and Tomizawa (1), and another by Staudenbauer
(2). These systems have been used for studying Col El and, more recently,
RSF1030 replication (3; for summary see Refs. 4 and 5). These two plasmids
have very similar replication properites. Both are present in multiple (20-
30) copies per cell, and continue to replicate in the presence of chloram-
phenicol resulting in the accumulation of 1000-1500 copies per cell (4,6).
In vivo replication of both plasmids requires DNA polymerase I and is inhi-
bited by rifampicin (4,6,7). In the absence of DNA polymerase III, the rate
of replication is decreased (7,8). In addition, both plasmids replicate
unidirectionally from a unique origin (4,9). In spite of these similarities,
plasmids Col El and RSF1030 appear to have evolved independently since they
have no detectable sequence homology (6).
The two in vitro systems currently in use have several major flaws. In
one (1), the rate and extent of synthesis is very low, and the extracts are
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unstable. In the second (2), the extent of synthesis is increased, but there
is endogenous plasmid DNA present in the extracts. It is desirable to use
an in vitro system in which synthesis is dependent upon the addition of ex-
ogenous template in order to be sure that initiation is occurring in vitro
and that synthesis does not reflect mere elongation of intermediates formed
in vivo.
In the work presented here, we have extended the system of Staudenbauer
by removing endogenous DNA and by concentrating extracts to allow increased
levels of synthesis. The extent of synthesis we observe in vitro is almost
three times greater than previously observed, making quantitative measure-
ments and purification of products easier. Furthermore, the system is
completely dependent upon the addition of exogenous, covalently-closed cir-
cular duplex DNA, allowing one to look at the replication of any desired
added DNA or DNA's.
MATERIALS AND METHODS
Bacterial Strains and Plasmids--E. Coli W3110 and E. coli W3110
(RSF1030) were used as the standard strains for preparation of the in vitro
system. Strains used to test for protein requirements are available on
request. RSF1030 is a relaxed plasmid (4) that carries ampR on the trans-
poson Tn 2 (6,10).
Other Materials--Nalidixic acid, novobiocin and streptomycin sulfate
were obtained from Sigma. Rifampicin was Rifampin from Calbiochem. Chlor-
amphenicol was chloromycetin sodium succinate, Parke-Davis. [3H]dTTP
(10 Ci/mmol)and [a-32P]dTTP (300 Ci/mmol) were purchased from New England
Nuclear. Agarose (Seakem, ME) was from Marine Colloids, Inc.
Growth of Cells--2 liters of E. coli W3110 (RSF1030) were grown at 370
to O.D.5901.O in L Broth supplemented with 0.1% glucose. Chloramphenicol
(150 }g/ml) was added and the culture incubated for 4 h with shaking at 370
(O.D.590=3.6). Cells were harvested at room temperature and resuspended in
10 ml 0.025 M HEPES, pH 8.0/5 mM EGTA. The cells were frozen in liquid N2.
Preparation of Extracts--Frozen cells were thawed by incubating at 00
for 20 min and then at 200. The lysis procedure used was that of Stauden-
bauer (2). The cell suspension was brought to a final concentration of
0.15 M KC1 and 0.2 mg/ml lysozyme. After incubation at O° for 30 min the
lysate was frozen in liquid N2 for 2 min and then thawed at 200. The lysate
was centrifuged for 30 min at 100,000 X 9. Thesupernatantfluid, which will
be referred to as Fraction I, contains about 17 mg per ml of protein and
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has an A260 of 100-130.
Streptomycin Sulfate and Ammonium Sulfate Fractionation--To 2.0 ml of
Fraction I, 0.2 ml of a 30 percent (w/v) solution of streptomycin sulfate
was added. The solution was stirred for 30 min at 0°C. The precipitate was
removed by centrifugation for 10 min at 20,000 X g at 40C. To 2.0 ml of
supernatant, 0.944 g solid ammonium sulfate was added over a 10 min period.
The mixture was stirred for 30 min at O° and the precipitate was then re-
moved by centrifugation at 20,000 X g for 10 min. The pellet was dissolved
in 1.0 ml 0.01 M HEPES, pH 8.0/1 mM DTT/l mM EDTA/ 0.1 M KC1/10% ethylene
glycol. The redissolved pellet was dialyzed against 100 ml of the same
buffer for 3 h at O°. The dialyzed material, Fraction II, was frozen and
stored in liquid N2. Fraction II contains about 11 mg per ml of protein.
Assay for DNA Synthesis--A standard assay for DNA synthesis has been
established using Fraction II. Reactions (0.05 ml) contained 40 mM HEPES,
pH 8.0, 100 mM KCI, 12 mM magnesium acetate, 50 uM each dCTP, dGTP, dATP,
and [3H]TTP, 2 mM ATP, 0.5 mM each rCTP, rGTP, rUTP, 1.5 nmol of RSF1030
DNA, and 20 pl extract. Incubations were carried out at 30°. Reactions
were terminated by placing tubes at 0° followed by addition of 1 N HCO con-
taining 0.1 M sodium pyrophosphate. The precipitate was collected on
Whatman GF/C filters. The filters were washed, dried and radioactivity
determined in a toluene-based fluid in a scintillation counter. The half-
life of the DNA synthesizing activity was greater than 60 min at 30° in
Fractions I and II. Fraction II has a half life of >60 min at 400.
Preparation of Plasmid RSF1030 DNA--E. coli HMS 174 recAl (RSF1030) was
grown to O.D.590=l.0 in Vogel-Bonner medium (11). Chloramphenicol (250pg/rl)
was added and incubation continued for 17 h. Cells were harvested by cen-
trifugation at 40, and frozen and thawed one time. Cells (25 g) were lysed
by the method of Clewell and Helinski (12), modified by the use of Triton
X-100 in place of Brij 58 and sodium deoxycholate (13).
Supercoiled DNA was purified by two equilibrium bandings in CsCl
(p=l .55)/EtdBr (100 .g/ml) gradients. In order to remove low molecular
weight nucleic acid contaminants, the DNA was sedimented through 30 ml CsCl
(p=1.3 gm/cc) containing 100 tg/ml EtdBr with a CsCl (p=1.7 gm/cc) cushion.
EtdBr was removed by Dowex chromatography and CsCl was removed by dialysis.
Agarose Gel Electrophoresis--Vertical slab gels (7 5/8" x 6 1/2" x 4mm)
of 0.7% agarose were formed and run in E buffer (40 mM Tris, 5 mM NaAcetate,
1 mM EDTA, pH 7.4) as described previously (9). Samples were loaded in low
salt buffer plus 2.5% Ficoll, and 0.02%bromophenol blue inamaximum volume of
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50 pl for a ten slot gel. Neutral agarose gels were run at 40V for 12 hrs
to resolve the different forms of circular DNA. For autoradiography, gels
were first dried on a Slab Gel Dryer (Hoefer Sci. Instruments). Preflashed
Kodak Xr-5 film was exposed at -70°C using an intensifying screen.
RESULTS
As pointed out in the Introduction, one goal of these studies was to
develop an in vitro replication system dependent on the addition of exogenous
DNA. Although one approach would be to prepare extracts from cells that do
not carry plasmid, such extracts would not contain products specified by
plasmid genes and one could not assess their role, if any, in plasmid
replication. We therefore chose to prepare extracts from cells carrying the
plasmid and to subsequently remove endogenous plasmid from the extracts.
Since lability of the extracts made such fractionation difficult, we first
established conditions for stabilizing the replicating activity. Sucrose
and glycerol proved inhibitory (2,3). Ethylene glycol, however, proved an
efficient stabilizing chemical and we have been able to develop a system
(see Methods, Fraction II) that is totally dependent on addition of exogen-
ous covalently closed, circular, duplex plasmid DNA.
In order to be sure that synthesis in Fraction II represented replica-
tion and not repair, Fraction II was compared to Fraction I with respect to
the requirements for synthesis, the effect of inhibitors, and the nature of
the products. Fraction I has been shown by others to represent replication
(2).
Kinetics of Synthesis in Fraction I and Fraction II--The kinetics of
RSF1030 DNA synthesis in Fraction I confirm the findings of Staudenbauer
et al. (2). As shown in Figure 1, synthesis proceeds at a linear rate for
40 minutes and then plateaus at around 60 minutes. After an initial lag
period of 10 minutes, the kinetics of synthesis in Fraction II, also shown
in Fig. 1, are somewhat different. The rate is 30-50% higher than observed
in Fraction I, with synthesis continuing at an almost linear rate for up to
90 minutes before a plateau is reached. The extent of synthesis obtained
with Fraction II is almost three-fold that seen in Fraction I. As in
Fraction I, however, a 10 minute lag period is observed before the synthesis
increases at a linear rate. The initial rate of synthesis in Fraction II
after the 10 minute lag is 180 pmols of dTMP incorporated per hour, or the
equivalent of 2.6 x 1010 RSF1030 molecules per hour. Since the reaction
mixture contains protein from 6 x 109 cells, this rate represents 4.5
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Figure 1. Kinetics of RSF1030
DNA Synthesis in Fractions I and
II. Fractions I and II were
prepared as described under
"Materials and Methods." The
kinetics of synthesis were then
measured using standard reaction
conditions described under
"Materials and Methods."
RSF1030 molecules per hour per cell equivalent.
Requirements of the Reaction and Effects of Inhibitors--The require-
ments of the in vitro synthesis reaction in Fractions I and II were com-
pared and are shown in Table I. Results with Fraction II are exactly the
same as with Fraction I and are similar to those in other related in vitro
Table I
Requirements for DNA Synthesis in vitro
Conditions Fraction I Fraction II
Table I. DNA synthesis activity was measured in the standard assay as de-
scribed in "Materials and Methods," using either Fraction I or Fraction II
prepared from E. coli W3110(RSF1030). In the complete system 120 pmol and
200 pmol of [3H]TMP represent 100% incorporation of [3H]TMP into acid-
insoluble product using Fraction I and Fraction II, respectively.
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Complete 100 100
- MgAc < 0.3 < 0.3
- dCTP, dGTP, dATP < 0.3 < 0.3
- dATP N.D. 66
- dCTP or dGTP N.D. 34
- rCTP, rGTP, rUTP < 0.3 < 0.3
- rATP < 0.3 < 0.3
- DNA 60-80 < 0.3
40 mM KC1 80 80
Rifampicin (5 vg/ml) 1 1
Novobiocin (1 ,ug/ml) 1 1
Nalidixic Acid (50 }g/ml) 43 40
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systems (1,2). The most important similarities are the requirement for ri-
bonucleotides and the inhibition of synthesis by rifampicin. Inhibition by
rifampicin indicates that RNA polymerase is required for synthesis in
Fraction II, and is strong evidence in itself that Fraction II carries out
replication and not repair synthesis. The kinetics of rifampicin inhibition
in Fraction II (Fig. 2) are the same as those reported by others (1) and
show that, in Fraction II as in Fraction I, rifampicin inhibits only ini-
tiation. Inhibition of Fraction II by novobiocin and nalidixic acid further
shows its similarity to Fraction I and implicates DNA gyrase (14,15) in
synthesis in Fraction II (Table I, Fig. 2b).
Template Requirement in Fraction II--As shown in Fig. 3 and Table I,
the amount of DNA synthesis in Fraction I in the absence of exogenous DNA
is 63% of that observed in the presence of 10 pg/ml of added Form I RSF1030
DNA. In Fraction II, however, the amount of synthesis in the absence of DNA
is <0.3% of the maximum observed when DNA is added to a final concentration
of 10 ig/ml, indicating the complete dependence of synthesis in Fraction II
upon exogenous DNA.
The initial rate of synthesis in Fraction II (after the 10 min lag) is
proportional to the amount of DNA added to the reaction, although high con-
centrations are inhibitory (Fig. 3). Optimal synthesis is obtained when
RSF1030 is added to a final concentration of 10 vg/ml, which represents a
total of 5.3 x 1010 RSF1030 template molecules per reaction, or 9 molecules
per cell equivalent of Fraction II added to the reaction. Since maximum
|I I Figure 2. A. Inhibition of
RIFAMPICIN NOVOBIOCIN synthesis in Fraction II by
/0/a)(b) Rifampicin. The kinetics of
80 / synthesis were measured in
7 20' / the standard reaction mixture.70 / y 7 At times marked on the curves,
> 60C _ 1/ / _ rifampicin (10 ,ug/ml) was
H g / added to individual reaction
> 5C /Y / _ mixtures and synthesis was
F40C ~ D lo/0allowed to continue in the
<30-/ presence of the drug. The20' extent of synthesis was de-
20 / termined at the times indi-
cated on the abscissa.
10
_0'- B. Inhibition of synthesis
0 10 0'= in Fraction II by novobiocin.
0 20 40 60 0 20 40 60 The kinetics of inhibition
MINUTES of synthesis by novobiocin
(1 Pg/ml) were measured as
described for rifampicin.
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Figure 3. Effect of DNA concen-
trat ion on the rate of DNA syn-
thesis in Fractions I and II.5 120-
E Reactions were carried out in
Q Fraction I the standard reaction mixture
_00_ except that the concentration
Q) f b of RSF1030 DNA was varied as
U 80 ' shown.
0
Fraction I
40
20 _ s
10 20 30
RSF1030 DNA (,/Lg/ml)
synthesis ranges from 4.5 to 8 RSFl030 molecules produced per cell equivalent,
depending on the extract used, 40-90% of the template, at most, is partici-
pating in replication. This is a more efficient use of template than in any
other in vitro plasmid replication system.
The DNA requirement of Fraction II parallels the requirement for DNA
observed in Fraction I extracts prepared from cells that carry no endogen-
ous plasmid. However, the overall rate of synthesis in the latter extracts
is always about three-fold less than the rate observed in extracts prepared
from plasmid carrying cells.
COMPARISON OF THE PRODUCT IN FRACTIONS I AND II
Sucrose Gradient Analysis--RSFl030 DNA synthesized in an in vitro re-
action containing covalently closed RSFl030 as template and [a-32P]TTP has
been analyzed by zone sedimentation through neutral and alkaline sucrose
gradients (Fig. 4). Results using Fraction I are presented for comparison
with Fraction II. These results clearly show that products are formed in
approximately the same ratios in reactions catalyzed by either Fraction I
or Fraction II. Although the proportion of newly synthesized DNA in each
peak varies somewhat from experiment to experiment, the product distribution
is identical to that found in Staudenbauer's Fraction I (2) and compatible
with that found in the detergent lysis system (1), where synthesis is known
to represent replication and not repair. In summary, distribution of
product suggests that up to 90% of the molecules that initiate replication
in vitro complete replication, while the remainder are present as partially
replicated molecules.
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Figure 4. Sucrose gradient analysis of RSF1030 DNA synthesized in vitro.
DNA was synthesized in an 0.1 ml reaction mixture containing [a-32P]TTP
(259 cpm/pmol) at 30° for 60'. The reaction was terminated by addition of
EDTA and the reaction mixtures were extracted lx with 0.2 ml phenol. 0.02
ml sodium acetate (10% w/v) was added and DNA precipitated by addition of
0.4 ml 95% ethanol followed by incubation at -70° for 10 min. The pellet
was recovered by centrifugation, washed once with 70% ethanol (0°) and
redissolved in 0.1 ml of 0.01 M HEPES-1 mM EGTA. An aliquot of each reac-
tion was then analyzed by sedimentation through a neutral or alkaline
sucrose gradient in an SW41 rotor at 35,000 rpm. A) neutral, 9 h centri-
fugation; B) alkaline, 9 h centrifugation; C) alkaline, 16 h centrifugation.
Sedimentation is from the right to left. [3H]RSF1030 and [3H]SV40 Form I
and Form II were included in each gradient at internal markers. Positions
of [3H]RSF1030 Form I and II are indicated by arrows and S values calculated
from the positions of [3H]SV40 markers.
Gel Electrophoresis--Despite the large number of similarities between
Fractions I and II already shown we wished to demonstrate that newly
synthesized DNA was not covalently attached to the template. Synthesis was
carried out using an RSF1030 template and [ca-32P]TTP (200 cpm/pmol) in the
standard reaction mixture for sixty minutes. The products were phenol ex-
tracted and ethanol precipitated and analyzed on 0.7% agarose gels (Fig. 5),
prior to (Lanes 2 and 4) and after denaturing and renaturing (Lanes 3 and
5). Lanes 2 and 3 (EtdBr stained) give information about both template and
product. Lanes 4 and 5 are autoradiograms of Lanes 2 and 3 and therefore
only represent newly synthesized DNA.
Prior to denaturation, completely replicated molecules are seen at
the position of Form I DNA (16) (Lanes 2 and 4). In addition, labeled DNA
products are seen at the position of Form II and in two other bands, one
migrating between Forms I and II, designated RI a, and a second migrating
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Analysis of RSF1030 DNA Synthesized
in Vitro by Gel Electrophoresis
1 2 3 4 5
R I,8-
D+C-
R IX
I-
t rr AuToroaaogrom
Figure 5. Agarose gel electrophoresis of RSF1030 DNA synthesized in vitro.
RSF1030 DNA was synthesized in an 0.1 ml reaction mixture for 1 h at 300.
The reaction was terminated and DNA prepared for electrophoresis as in
Fig. 4. One sample (0.05 ml) was heated at 900 for 90 sec before applica-
tion to the gel. Samples were electrophoresed and gels autoradiographed
as described previously (2) and in "Methods." Lane 1, RSF1030 Form I and
Form II markers, D + C are dimers and catenated dimers; Lane 2, products
of RSF1030 synthesis stained with EtdBr; Lane 3, DNA heated at 900 for 90
sec before electrophoresis; Lane 4, autoradiogram of Lane 2; Lane 5,
autoradiogram of Lane 3.
slower than Form II indicated as RI There is 32p labeled material appear-
ing througout the gel from the position of Form I DNA to the position of
the most slowly migrating band. The material has been eluted from these
regions of the gel, and analysis by electron microscopy indicates that they
are circular replicative intermediates representing different extents of
replication (9).
Upon denaturation of the product, Lanes 3 and 5, all of the labeled
material above the Form II position disappears, as does the diffuse material
between Forms I and II. A new band, which we have not characterized,
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appears just below the Form II position. The amount of Form I material
increases, and diffuse label now appears below the Form I position, pro-
bably representing less than full length linear molecules that have been
released by denaturation from replicative intermediates. There are
several very broad bands apparent in this region, indicating that replica-
tion may be prematurely terminated at several distinct sites. Thus, at
least some of the newly synthesized DNA is not covalently attached to the
template since it can be released by brief heating of the DNA. That the
amount of Form I DNA appearing in the autoradiogram after the product is
heated also increases suggests that some of the newly synthesized and
therefore 32p labeled DNA served as a template for new rounds of replica-
tion in vitro.
Neutral agarose gels do not distinguish between nicked and relaxed
closed circles (Form II and Form Io (16), respectively). In order to do
this, newly synthesized DNA was analyzed on an agarose gel containing
EtdBr, a system we found readily distinguishes Forms II and Io (data not
shown). There is little Form Io DNA--most DNA migrates as Form I, II
or the intermediates described above. We do not know whether the nicked
forms are late intermediates in replication or arise due to random nicking
activity in the extract or in the purification procedure used in preparing
the DNA for gel analysis.
Further Characterization of Product--Because of the good correspondence
between the requirements for synthesis and products of synthesis in Frac-
tions I and II, and because the product was not all covalently attached to
the template, no further product characterization by density gradients was
considered necessary to prove that synthesis represented replication. This
conclusion is supported below by the fact that a number of proteins known
to be required for replication in vivo,but not thought to be repair enzymes,
are absolutely required for DNA synthesis. Most importantly, however,
we have shown by electron microscopy and gel electrophoresis that replica-
tion in Fraction II is initiated at a unique site and proceeds sequentially
and unidirectionally (9). This result could only be due to replication and
rules out the possibility that we are looking at repair synthesis, even in
completely replicated molecules.
The above studies have been repeated with hosts not carrying endo-
genous plasmid. The results are identical, indicating that if any plasmid
protein is involved in replication, a host protein can substitute for it.
Mutations Affecting DNA Polymerases--DNA polymerase I is required for
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plasmid replication in vivo (4) and has been shown to be required for Col
El and RSF1030 replication in vitro in Fraction I (2,7). In addition, DNA
polymerase III is implicated in plasmid replication in vivo since in polC
mutants synthesis slows down, although it does not cease completely.
Staudenbauer has also shown that DNA polymerase III is required for plasmid
replication in vitro (7,17). Fraction II was prepared from polA or polC
mutants as a further test that Fraction II was actually carrying out DNA
replication.
Fraction II was prepared from E. coli DK517', which contains a ther-
molabile DNA polymerase I. No replication was found whether the extract
was first incubated at 300 or at 400. Evidently the activity in strain
0K517' is defective in vitro even at the temperature that permits RSF1030
replication in vivo. This confirms that DNA polymerase I is required in
vitro in Fraction II as well as in vivo and, as Staudenbauer has already
shown, in Fraction I (17). Identical results were obtained with a polAl
mutant.
Extracts of strain BT1026 polAl polCts supplemented with purified DNA
polymerase I carries out synthesis at 30°, but not at 37° (17). Fraction II
was prepared with E. coli dnaE486, which Livingston et al. (18) have shown
contains no detectable DNA polymerase III activity in vitro. We found that
there was no RSF1030 replication at any temperature in extracts of dnaE486
mutants, confirming that in Fraction II, as in Fraction I, DNA polymerase
III is absolutely required for replication.
The usefulness of an invitro replication system lies in its ability
to give new insight into the mechanism of DNA replication, and a great deal
has been learned about the molecular biology of plasmid replication from
in vitro replication studies. Requirements for DNA gyrase, RNA polymerase,
DNA polymerase I and DNA polymerase III have recently been demonstrated (4).
We have used Fraction II to investigate the additional protein requirements
for plasmid replication.
A summary of the gene products required in vivo for plasmid replica-
tion is found in Ref. 4. We have prepared Fraction II from a number of
mutants of E. coli defective in these required functions (dnaA, dnaB, dnaC,
dnaE, and dnaG) and from several mutants defective in other functions not
yet identified with plasmid replication in vivo, but that have phenotypes
that suggest they might be (dnaZ, dnaP, dnaI). Extracts were prepared in
most cases from strains that harbored RSF1030. Extracts from strains dnaG,
dnaZ, and dnaI, however, did not contain endogenous plasmid. It remains to
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be seen, therefore, if a plasmid gene product suppresses the requirement for
any of these three activities. A summary of the results obtained using these
mutants and corresponding revertants is shown in Table II. Staudenbauer has
also demonstrated requirements for dnaB, dnaC, and dnaZ (19).
A complementation assay has been developed for the purification of
dnaP protein based on the data in Table II. Addition of Fraction II prepared
from E. colipolAlpolBlOOpolCts stimulates synthesis in Fraction II from dnaP
stains 3-fold, and the protelin has been partially purified using this as an
assay (unpublished data). In addition, purified RNase III added to Fraction
II prepared from E. coli rnc restores DNA synthesis (20,21),indicating that
Fraction II can be complemented by purified proteins.
Table II
Requirements for E. coli Proteins for RSF1030 DNA Synthesis in vitro
Activity
Gene
Parent or Revertant Mutant
(pmol) (pmol)
dnaA 129 131
dnaB 129 1.0
dnaC 70 1.5
dnaE(polC) N.D. 1.0
dnaG 28 2.8
dnaI 128 11.7
dnaP 81 12.5
dnaZ N.D. 3.5
polA N.D. 1.0
rnc 238 4.5
Table II. Fraction I and II were prepared from a strain carrying the muta-
tion indicated on the left. A list of strains used is appended. For dnaA,
dnaC, dnaI, and dnaP, extracts were prepared from isogenic parental strains
as controls. For dnaG and dnaB, revertants were prepared by plating liquid
cultures in soft agar and incubating at 42'. Synthesis was measured in
Fraction I and Fraction II, but only results using Fraction II are presented.
In all cases, 20 4l of Fraction II were incubated in the standard reaction
mixture containing 0.1 mM DTT, but without DNA, for 0, 10, 20, 30 or 40 min
at 40'. RES1030 DNA (10 ig/ml) was then added and synthesis measured for
60 min at 30'. The results with dnaA represent activity after 40 min at
400. Values for all other strains represent synthesis after 0 min at 40'.
Since 3 separate revertants of dnaB266 gave no activity, the result with
the parental strain is used as control.
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DISCUSSION
An improved in vitro system for studying plasmid DNA replication has
been developed. The extent of synthesis observed in this system is approxi-
mately 4x that seen in the previous system. More importantly, synthesis is
now completely dependent upon the addition of exogenous Form I DNA, although
the cells from which the extracts are made contain endogenous plasmids.
Evidence obtained in vivo using plasmids and chloramphenicol-treated cells
indicates that no plasmid coded proteins are required for Col El replication
(22,23), but does not discount the possibility that such gene products are
normally involved in replication or can replace host proteins. Recently,
Helinski has shown that in vitro replication of the transmissable, multi-
copy plasmid R6K does require an R6K encoded protein (24).
Analysis of the products synthesized in vitro both sucrose gradients
and gel electrophoresis indicates that both fully and partially replicated
molecules are formed during the reaction and that the newly synthesized DNA
in the partially replicated molecules is not covalently attached to the
template. Electron microscope studies of partially replicated molecules
have, in fact, allowed us to map the origin and direction of RSF1030
replication (9). This system is dependent upon RNA polymerase, DNA polymer-
ase I and III and DNA gyrase, as has been reported in earlier systems. In
addition, the products encoded by the genes dnaB, dnaC, dnaG, dnaP, and
dnaI appear to be required for plasmid DNA replication.
The increased amount of synthesis in this system makes it ideal for
studying individual steps of the replication reaction. For example, many
of the dnats mutants contain low residual levels of activity, that represent
enough synthesis so that the replicative intermediates can be isolated.
Analysis of these DNA molecules can provide information about the stage of
the reaction at which the protein is required. Staudenbauer has shown that
in dnaZ extracts, the product is 7S and can be elongated into completed 26S
molecules by further indubation with polymerase III in the presence of ri-
fampicin to prevent additional initiations (3). Although he has not ana-
lyzed this DNA, he has used it to study proteins required for its elongation.
A similar approach will be helpful in analyzing residual activity in dnaI
and dnaG mutants. In our hands, the levels of synthesis seen with polymer-
ase III, dnaE, and dnaC mutants are probably too low to examine which DNA
products are involved at which step. However, we can isolate intermediates
and add them to these mutant extracts in order to observe their fate. Future
studies will be aimed at separating the reaction into stages, and looking at
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interactions of all the proteins involved.
One of the main advantages of the system has been to establish comple-
mentation assays for several proteins previously known from genetic evidence
to be involved in E. coli replication, but not required in various in vitro
phage replication systems. For instance, we have used the system to partial-
ly purify the dnaP protein (unpublished results), a protein thought to be
involved in initiation of chromosomal DNA replication. We have also used
complementation with purified RNase III to show that this enzyme, and there-
fore, perhaps RNA processing, is involved in DNA replication (20).
A novel use of the system, made possible by its dependence on exogenous
DNA, has been its application as an in vitro transcription system. Using
Fraction II in this capacity, we have shown that the coding sequence for a
small 100 nucleotide RNA is involved in controlling plasmid copy number (20).
Currently we are using this in vitro replication system to test complemen-
tation between self-replicating and non-self-replicating mutant DNAs missing
the RNA coding sequence to study the mechanism by which the RNA exerts its
effect. Complementation in vitro has the advantage that incompatibility
phenomena that make in vivo results difficult to interpret are avoided.
ABBREVIATIONS
Form I, covalently closed circular duplex supercoiled DNA; Form IO1
covalently closed circular duplex relaxed DNA; Form II, nicked, circular
duplex DNA; Form III, linear, duplex DNA; DTT, dithiothreitol; HEPES,
N-2-hydroxyethylpiperazine-N'-2'ethane'sulfonic acid; EGTA, ethylene-glycol-
bis-(8-aminorethyl ether)N, N'-tetra-acetic acid, N.D., not determined.
ACKNOWLEDGMENTS
This investigation was supported by grants from the United States
Public Health Service: RR07003 and GM 25508. S.E.C. was supported by
United States Public Health Service Training Grant No. 5 T32 GM 07616.
REFERENCES
1. Sakakibara, Y. and Tomizawa, J. (1974) Proc. Natl. Acad. Sci. USA 71,
802-806.
2. Staudenbauer, W.L. (1976) Molec. Gen. Genet. 145, 273-280.
3. . (1977) Molec. Gen. Genet. 156, 27-34.
4. . (1978) Curr. Topics Microbiol. Immunol. in press.
5. Wickner, S. (1978) Ann. Rev. Biochem. 47, 1163-1191.
6. Crosa, J.H., Luttrop, L.K., and Falkow, S. (1975) Proc. Natl. Acad.
Sci. USA 72, 654-658.
7. Falkow, S. (1975) Infectious Multiple Drug Resistance, pp. 116-117.
Pion Limiited, London.
3302
Nucleic Acids Research
8. Collins, J.P., Williams, P.H., and Helinski, D.R. (1975) Molec. Gen.
Genet. 136, 372-289.
9. Conrad, S.C., Wold, M. and Campbell, J.L. (1979) Proc. Natl. Acad. Sci.
USA 76, 736-740.
10. Heffron, F., Sublett, R., Hedges, R., Jacob, A., and Falkow, S.
(1975) J. Bacteriol. 122, 250-256.
11. Vogel, M.J. and Bonner, D.M. (1956) J. Biol. Chem. 218, 97-106.
12. Clewell, D.B. and Helinski, D.R. (1969) Proc. Natl. Acad. Sci. USA
62, 1159-1166.
13. Kuperszotch, Y.M. and Helinski, D.R. (1973) Biochem. Biophys. Res.
Comm. 54, 1451-1459.
14. Gellert, M., O'Dea, M.H., Itoh, T., and Tomizawa, J. (1976) Proc.
Natl. Acad. Sci. USA, 73, 4474-4478.
15. Gellert, M., Muzuuchi, K., O'Dea, M.H., Itoh, T., and Tomizawa, J.
(1977) Proc. Natl. Acad. Sci. USA 74, 4772-4776.
16. Weil, R. and Vinograd, J. (1963) Proc. Natl. Acad. Sci. USA 50, 730-738.
17. Staudenbauer, W.L. (1976) Molec. Gen. Genet. 149, 151-158
18. Livingston, D.M. and Richardson, C.C. (1975) J. Biol. Chem. 250,
470-478.
19. Staudenbauer, W.L., Lanka, E., and Schuster, H. (1978) Molec. Gen.
Genet. 162, 243-249.
20. Conrad, S.E. and Campbell, J.L. (1979) Cell, in press.
21. Dunn, J.J. (1976) J. Biol. Chem. 251, 3807-3814.
22. Donahue, D.J. and Sharp, P.A. (1978) J. Bacteriol. 133, 1287-1294.
23. Kahn, M. and Helinski, D.R. (1978) Proc. Natl. Acad. Sci. USA 75,
2200-2204.
24. Inuzuka, M., Helinski, D.R. (1978) Biochemistry 17, 2657-2574.
3303
Nucleic Acids Research
Strain Designation
CRT46
PC5
CR34/43
PC1
PC 7
PC2
PC255
BT1026
E613
HMS1 21
El 01
PC3
WM437
WM301
KY2750
KY2053
DK517'
Lrl 07
APPENDIX A
STRAINS USED
Genotype
dnaA T46
dnaA
dnaB
dnaC
dnaC,D
dnaC
parent of PC1,2,5,7
polAl poliC
polC T486
polA1 polBlO0 polC1O26
dnaF
dnaG
dnaI 208
dnaI+
dnaP 18
dnaP+
pol Ats
rnclO5
Source
Y. Hirota
P. Carl
Y. Hirota
P. Carl
P. Carl
P. Carl
P. Carl
H. Bonhoeffer
Y. Hirota
J. Campbell
Y. Hirota
Y. Hirota
W. Messer
W. Messer
T. Yura
T. Yura
D. Kingsbury
W. Studier
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